Effects of Growth Hormone (GH) Treatment on Eating Regulation

NCT00562705 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2013-07-16

No results posted yet for this study

Summary

This is a two arm, randomized, prospective, intervention study in order to determine the effects of growth hormone treatment on eating regulation and to compare between the growth responses with or without nutritional intervention in short stature children.

The study will include 30 short stature children that are about to initiate growth hormone treatment and will last for one year. After 4 months of treatment, children will be randomized into two groups:

1. Control group that will continue with growth hormone treatment without any other intervention.
2. Study group that will be a given a nutritional intervention in addition to growth hormone treatment.

At screening visit and during the study the following parameters will be evaluated: height, weight, growth markers in the blood and urine, child eating behavior questionnaire, blood tests, hormonal tests and resting energy expenditure measurements.

Conditions

  • Short Stature

Interventions

BEHAVIORAL

growth hormone- Genotropin or NorditropinSimplex and nutritional intervention

A combined treatment of growth hormone (Genotropin or NorditropinSimplex or "Biotropin") and nutritional intervention

BEHAVIORAL

growth hormone-Genotropin or NorditropinSimplex or "Biotropin"

Growth hormone treatment (Genotropin, or NorditropinSimplex or "Biotropin").

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Moshe Phillip, Professor · Schneider Children Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00562705 on ClinicalTrials.gov